L. Moreau
Hopitaux Civils de Colmar(FR)Santé Publique France(FR)Observatoire de Physique du Globe de Clermont-Ferrand(FR)Hôpital Pasteur(FR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Neuroendocrine Tumor Research Advances
Most-Cited Works
- → Phase II Comparator Study of Oral Versus Intravenous Topotecan in Patients With Chemosensitive Small-Cell Lung Cancer(2001)233 cited
- → Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study(2017)161 cited
- → Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial(2005)95 cited
- → First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer(2025)77 cited
- → Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies(2022)70 cited
- → Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study